Hematology, Transfusion and Cell Therapy

Peripheral lymphocyte subsets as predicting factors for molecular recurrence after imatinib discontinuation in a phase 2 imatinib discontinuation trial in patients with chronic myeloid leukemia Arthur Gomes Oliveira Braga; Katia Borgia Barbosa Pagnano; Marina Dal'Bó Pelegrini Campioni; Ana Beatriz Pascoal Lopes; Gislaine Oliveira Duarte; Konradin Metze; Irene Lorand-Metze;

Impact of the changes in chronic myeloid leukemia classification proposed by the 2022 World Health Organization: a single-center Brazilian study Estela Gasparotto Emiliano; Gustavo Emmanuel Alves Abrantes Santos; Eliana Cristina Martins Miranda; Gislaine Borba Oliveira Duarte; Guilherme Brasil Duffles Amarante; Carmino Antônio De Souza; Katia Borgia Barbosa Pagnano;

Epidemiological characterization of chronic myeloid leukaemia patients at an oncologic centre: A retrospective observational study Ana Maria Meireles; Rita Calisto; Maria José Bento; Pedro Martinho Gouveia; Susana Bizarro; Manuel Teixeira; Cláudia Moreira; Ana Espírito Santo; Mário Mariz;